Skip to content
DefDex

Federal award

HARRIS PHARMACEUTICAL, INC

SPE2D015D0002

Contract vehicle (IDV)IDV: ceiling is not spending

Obligated and Ceiling

Obligated (net)
$0.00
Vehicle ceiling (not spending)
$55,913,776.33
Current value
—
Gross positive obligations
$0.00

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient
HARRIS PHARMACEUTICAL, INC · NK36JG38GKH5
Owner company
Not a reviewed companyNo reviewed company owns this recipient.
Reported parent
HARRIS PHARMACEUTICAL, INC · NK36JG38GKH5
Awarding agency
Department of Defense · sub-agency 97AS · office SPE2D0
Funding agency
Department of Defense · sub-agency 97AS
Product or service (PSC)
6505 · DRUGS AND BIOLOGICALS
Industry (NAICS)
325411 · MEDICINAL AND BOTANICAL MANUFACTURING
PIID
SPE2D015D0002
Award type code
B
Actions
14 · May 7, 2015 to May 1, 2019
Why it is listed
contract vehicle (IDV)

Open this award on USAspending →

Action History14

Award actions
DateFYModAction typeObligationCompany in company totals
May 1, 2019FY2019P00015M$0.00
—
May 4, 2018FY2018P00014G$0.00
—
May 4, 2018FY2018P00013G$0.00
—
Jan 10, 2018FY2018P00011G$0.00
—
Apr 5, 2017FY2017P00010G$0.00
—
Apr 3, 2017FY2017P00009B$0.00
—
Dec 6, 2016FY2017P00008M$0.00
—
Sep 7, 2016FY2016P00007M$0.00
—
May 2, 2016FY2016P00006G$0.00
—
Apr 4, 2016FY2016P00005M$0.00
—
Sep 2, 2015FY2015P00004M$0.00
—
Aug 13, 2015FY2015P00003M$0.00
—
Jun 10, 2015FY2015P00002B$0.00
—
May 7, 2015FY20150—$0.00
—

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.